Rocket Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $9,186 |
Gross Profit | -2,539 | -2,989 | 4,593 | |
EBITDA | -46,619 | -65,867 | -57,873 | -57,493 |
EBIT | -49,859 | -68,446 | -60,862 | -59,854 |
Net Income | -50,332 | -68,919 | -61,334 | -60,327 |
Net Change In Cash | 0 | 0 | 0 | 9,186 |
Free Cash Flow | -50,374 | -49,014 | -56,166 | -47,266 |
Cash | 75,948 | 32,819 | 49,810 | 163,635 |
Basic Shares | 111,571 | 111,019 | 110,093 | 97,530 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -9,375 | -7,098 | -6,266 | -5,373 |
EBITDA | -247,485 | -236,622 | -213,688 | -157,807 |
EBIT | -256,860 | -243,720 | -219,954 | -163,180 |
Net Income | -258,746 | -245,595 | -221,863 | -169,069 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -64,629 | |||
Free Cash Flow | -215,586 | -211,388 | -186,761 | -128,878 |
Cash | 163,635 | 55,904 | 140,517 | 232,694 |
Basic Shares | 94,807 | 84,009 | 68,148 | 63,235 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | $0 |
2025-09-30 | -$0.45 |
2025-06-30 | -$0.62 |
